Among 501 adults with type 2 diabetes, about 30% of users quit over side effects, and women reported more nausea and reflux than men.
Recap by typeshit. Full story at Everyday Health.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
Loading…